HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wenxiang Huang Selected Research

ginsenoside Rg1

3/2021Hepatoprotection by Ginsenoside Rg1 in alcoholic liver disease.
11/2020Effect and mechanism of ginsenoside Rg1-regulating hepatic steatosis in HepG2 cells induced by free fatty acid.
6/2020Ginsenoside Rg1 alleviates ANIT-induced intrahepatic cholestasis in rats via activating farnesoid X receptor and regulating transporters and metabolic enzymes.
1/2019Ginsenoside Rg1 Ameliorates Palmitic Acid-Induced Hepatic Steatosis and Inflammation in HepG2 Cells via the AMPK/NF-κB Pathway.
11/2018Ginsenoside Rg1 Protects against Non-alcoholic Fatty Liver Disease by Ameliorating Lipid Peroxidation, Endoplasmic Reticulum Stress, and Inflammasome Activation.
5/2018Ginsenoside Rg1 ameliorates liver fibrosis via suppressing epithelial to mesenchymal transition and reactive oxygen species production in vitro and in vivo.
2/2018Ginsenoside Rg1 inhibits inflammatory responses via modulation of the nuclear factor‑κB pathway and inhibition of inflammasome activation in alcoholic hepatitis.
8/2015[Effect and mechanism of ginsenoside Rg1 as an alcoholic hepatitis treatment in a rat model].
1/2014Ginsenosides Rg1 from Panax ginseng: A Potential Therapy for Acute Liver Failure Patients?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wenxiang Huang Research Topics

Disease

12Infections
12/2019 - 01/2010
8Chronic Hepatitis B
12/2019 - 03/2014
6Fibrosis (Cirrhosis)
06/2020 - 05/2018
5Urinary Tract Infections (Urinary Tract Infection)
12/2020 - 01/2010
4Liver Cirrhosis (Hepatic Cirrhosis)
07/2022 - 01/2014
4Non-alcoholic Fatty Liver Disease
07/2022 - 11/2018
4Liver Diseases (Liver Disease)
03/2021 - 11/2019
4Intraabdominal Infections
12/2020 - 09/2013
3Neoplasms (Cancer)
01/2020 - 01/2018
3Alcoholic Hepatitis
01/2019 - 08/2015
3Bacterial Infections (Bacterial Infection)
12/2013 - 01/2010
2Necrosis
06/2020 - 02/2018
2Pneumonia (Pneumonitis)
01/2020 - 01/2017
2Hepatitis B
12/2019 - 05/2014
2Inflammation (Inflammations)
01/2019 - 11/2018
2Liver Failure
08/2018 - 06/2016
2Acute Liver Failure (Fulminant Hepatic Failure)
08/2018 - 01/2014
1Alcoholic Liver Diseases (Alcoholic Liver Disease)
03/2021
1Respiratory Tract Infections (Respiratory Tract Infection)
12/2020
1Enterobacteriaceae Infections
12/2020
1Ascites
06/2020
1Cholestasis
06/2020
1Intrahepatic Cholestasis
06/2020
1Fatigue
01/2020
1Fever (Fevers)
01/2020
1Dyspnea (Shortness of Breath)
01/2020
1Chronic Obstructive Pulmonary Disease (COPD)
01/2020
1Hypertension (High Blood Pressure)
01/2020
1Myalgia
01/2020
1Cystic Fibrosis (Mucoviscidosis)
01/2020
1Cough
01/2020
1COVID-19
01/2020
1Headache (Headaches)
01/2020
1Cardiovascular Diseases (Cardiovascular Disease)
01/2020
1Vitamin D Deficiency
11/2019
1Body Weight (Weight, Body)
09/2019
1Peritonitis
06/2019
1Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis)
01/2019
1Chronic Hepatitis (Chronic Active Hepatitis)
01/2019
1Communicable Diseases (Infectious Diseases)
01/2019
1Autoimmune Hepatitis
01/2019
1Wounds and Injuries (Trauma)
08/2018
1Leukemia
01/2018

Drug/Important Bio-Agent (IBA)

9ginsenoside Rg1IBA
03/2021 - 01/2014
4Carbapenems (Carbapenem Antibiotics)IBA
12/2020 - 01/2017
4CytokinesIBA
11/2018 - 08/2015
3Hepatitis B e AntigensIBA
05/2019 - 12/2014
3InterleukinsIBA
11/2018 - 01/2018
3Levofloxacin (Levaquin)FDA Link
05/2014 - 01/2010
2Messenger RNA (mRNA)IBA
07/2022 - 03/2016
2ImipenemFDA Link
12/2020 - 01/2017
2GinsenosidesIBA
06/2020 - 01/2014
2Hepatitis B Surface Antigens (HBsAg)FDA Link
12/2019 - 10/2016
2Anti-Bacterial Agents (Antibiotics)IBA
01/2019 - 01/2017
2Proteins (Proteins, Gene)FDA Link
01/2019 - 03/2016
2InflammasomesIBA
11/2018 - 02/2018
2NucleotidesIBA
11/2018 - 03/2016
2peginterferon alfa-2b (Pegintron)FDA Link
10/2016 - 12/2014
2Antiviral Agents (Antivirals)IBA
01/2015 - 05/2014
2Ceftriaxone (Ceftriaxon)FDA LinkGeneric
05/2014 - 12/2013
1MicroRNAs (MicroRNA)IBA
07/2022
1Competitive Endogenous RNAIBA
07/2022
1Long Noncoding RNAIBA
07/2022
1relebactamIBA
12/2020
1PhytochemicalsIBA
11/2020
1Interleukin-6 (Interleukin 6)IBA
06/2020
1EnzymesIBA
06/2020
1Guanosine Triphosphate (GTP)IBA
06/2020
1Indicators and Reagents (Reagents)IBA
06/2020
1Proton Pump InhibitorsIBA
05/2020
1Glutathione (Reduced Glutathione)IBA
01/2020
1RNA (Ribonucleic Acid)IBA
01/2020
1Vitamin DFDA LinkGeneric
11/2019
1danoprevirIBA
09/2019
1Ritonavir (Norvir)FDA Link
09/2019
1Ribavirin (Virazole)FDA LinkGeneric
09/2019
1Dinoprostone (PGE2)FDA Link
06/2019
1InterferonsIBA
05/2019
1Palmitic Acid (Hexadecanoic Acid)IBA
01/2019
1NF-kappa B (NF-kB)IBA
01/2019
1Immunoglobulin G (IgG)IBA
01/2019
1LipidsIBA
01/2019
1AMP-Activated Protein KinasesIBA
01/2019
1avibactamIBA
11/2018
1ceftazidime drug combination avibactamIBA
11/2018
1CeftarolineFDA Link
11/2018
1Interleukin-18 (Interleukin 18)IBA
11/2018
1NLR ProteinsIBA
11/2018
1astragaloside AIBA
08/2018
1Acetaminophen (Paracetamol)FDA LinkGeneric
08/2018
1CollagenIBA
05/2018
1Reactive Oxygen Species (Oxygen Radicals)IBA
05/2018
1Transforming Growth Factors (Transforming Growth Factor)IBA
05/2018
1BilirubinIBA
02/2018
1Alanine Transaminase (SGPT)IBA
02/2018
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
02/2018
1Interleukin-4 (Interleukin 4)IBA
01/2018
1Ertapenem (Invanz)FDA Link
01/2017

Therapy/Procedure

11Therapeutics
03/2021 - 12/2013
1Critical Care (Surgical Intensive Care)
01/2020